Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis.

Differences in the diagnostic value of a variety of definitions of negative T waves for HCM (hypertrophic cardiomyopathy) have not yet been clarified, resulting in a number of definitions being applied in previous studies. The aim of the present study was to determine the most accurate diagnostic definition of negative T waves for HCM in genotyped populations. Electrocardiographic and echocardiographic findings were analysed in 161 genotyped subjects (97 carriers and 64 non-carriers). We applied three different criteria that have been used in previous studies: Criterion 1, negative T wave >10 mm in depth in any leads; Criterion 2, negative T wave >3 mm in depth in at least two leads; and Criterion 3, negative T wave >1 mm in depth in at least two leads. Of the three criteria, Criterion 3 had the highest sensitivity (43% compared with 5 and 26% in Criterion 1 and Criterion 2 respectively; P<0.0001) and retained a specificity of 95%, resulting in the highest accuracy. In comparison with abnormal Q waves, negative T waves for Criterion 3 had a lower sensitivity in detecting carriers without LVH (left ventricular hypertrophy) (12.9% for negative T waves compared with 22.6% for abnormal Q waves). On the other hand, in detecting carriers with LVH, the sensitivity of negative T waves increased in a stepwise direction with the increasing extent of LVH (P<0.001), whereas there was less association between the sensitivity of abnormal Q waves and the extent of LVH. In conclusion, Criterion 3 for negative T waves may be the most accurate definition of HCM based on genetic diagnoses. Negative T waves may show different diagnostic value according to the different criteria and phenotypes in genotyped populations with HCM.

[1]  H. Mabuchi,et al.  Clinical Features of Hypertrophic Cardiomyopathy Caused by a Novel Val85Leu Missense Mutation in the Cardiac Troponin T Gene(Cardiomyopathy, Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2005 .

[2]  Masami Shimizu,et al.  Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. , 2004, European heart journal.

[3]  B. Maron,et al.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. , 2003, The American journal of cardiology.

[4]  M. Komajda,et al.  Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. , 2003, International journal of cardiology.

[5]  K. Hayashi,et al.  A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. , 2003, Journal of the American College of Cardiology.

[6]  K. Schulz,et al.  Uses and abuses of screening tests , 2002, The Lancet.

[7]  K. Hayashi,et al.  Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation. , 2002, American heart journal.

[8]  H. Mabuchi,et al.  Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy , 2001, Clinical cardiology.

[9]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[10]  H. Mabuchi,et al.  Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. , 2000, Circulation.

[11]  M. Komajda,et al.  Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. , 1998, Circulation.

[12]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[13]  M. Komajda,et al.  Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. , 1997, Circulation research.

[14]  T. Imaizumi,et al.  A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. , 1995, Circulation.

[15]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[16]  T. Sasazuki,et al.  Possible Gene Effect of a Mutant Cardiac β-Myosin Heavy Chain Gene on the Clinical Expression of Familial Hypertrophic Cardiomyopathy , 1994 .

[17]  J. Schleich,et al.  The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. , 1990, Genomics.

[18]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[19]  M. Davies,et al.  Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. , 1990, British heart journal.

[20]  P. Nihoyannopoulos,et al.  Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. , 1990, Journal of the American College of Cardiology.

[21]  T. Umeda,et al.  Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. , 1979, The American journal of cardiology.

[22]  C. Tei,et al.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. , 1976, Japanese heart journal.

[23]  E. H. Estes,et al.  A point-score system for the ECG diagnosis of left ventricular hypertrophy. , 1968, American heart journal.

[24]  H. Mabuchi,et al.  A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. , 2006, Clinical science.

[25]  H. Mabuchi,et al.  A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. , 2002, The American journal of cardiology.